web analytics

Category: Uncategorized



CTK’s OnSite Covid-19 Ag Rapid Tests detect newly identified U.K., South Africa, and Brazil SARS-CoV-2 variants

In December 2020, CTK shared that we had no reason to believe that the U.K. variant would affect the OnSite COVID-19 Ag Rapid Test’s performance, and we would work on confirmation studies.  Since then, multiple SARS-CoV-2 variants have been circulating globally, which led us to include them in our confirmation studies. The OnSite COVID-19 Ag Rapid Test detects the presence.... Read Full Article >



Ongoing studies indicate that CTK’s OnSite Covid-19 IgG/IgM Rapid Tests detect antibodies in response to COVID-19 vaccines

CTK’s OnSite COVID-19 IgG/IgM Rapid Test’s performance in detecting antibody responses following COVID-19 vaccination was evaluated in a cohort of 20 subjects that had no detectable levels of anti-SARS-CoV-2 antibodies before vaccination. All 20 subjects (100%) had their first positive result on the OnSite COVID-19 IgG/IgM Rapid Test 9 to 16 days post-vaccination, showing this test’s high sensitivity. Our ongoing.... Read Full Article >



CTK Launched RaFIA Immunofluorescence immunoassay System!

CTK has recently launched their latest system, meeting market demand for quantitative rapid tests: CTK’s RaFIA System! This quantitative system is easy to use while offering a high level of sensitivity and a broad working range.  By pairing the RaFIA Test with our Immunofluorescence Analyzer and Incubator, we have created a closed system that is Accurate, Fast, Flexible, and User.... Read Full Article >



AACC Recommendations for SARS-CoV-2 Serology Testing

From AACC post, May 18, 2020 There is broad recognition that the unprecedented COVID-19 pandemic requires clinical laboratory testing as part of the worldwide response to this health crisis. To detect SARS-CoV-2—the virus that causes COVID-19—in infected individuals, the primary laboratory tool has been molecular diagnostic tests. While these tests inform clinicians of individuals who are currently infected by identifying.... Read Full Article >



CTK’s rapid test used in COVID-19 mass testing in the Philippines

From CDN digital facebook post, May 18, 2020 CEBU CITY, Philippines — The Office of the Presidential Assistance for the Visayas’ (OPAV) Project Balik-Buhay (PBB) has revealed the four brands of rapid antibody-based test kits that are used in running the blood samples from the mass testing in the cities of Cebu, Mandaue and Lapu-Lapu. These test kits brand include.... Read Full Article >



Evolved Value Proposition of the OnSite COVID-19 IgG/IgM Rapid Test

  Window for Detection of SARS-COV-2 Infection SARS-COV-2 is a new virus, emergent to humans. Since its first report in December 2019, we have gained tremendous understanding of its transmission, virus replication in the human body, immune response, pathogenesis, clinical symptoms, diagnosis, and treatment. Nandini Sethuraman et al1 concluded a most comprehensive and sound laboratory testing window with different technologies based.... Read Full Article >



New! COVID-19 IgG/IgM Rapid Test

CTK’s COVID-19 IgG/IgM Rapid Test is suited for POC testing: Provides information on the previous infection Detects immune response and provides indication of likely immunity Aids in verifying if people can be released from quarantine and/or return to work   *For Export Only  



Visit us at MEDLAB in Dubai!

MEDLAB is next week and we’re excited to meet with you at booth Z3 A48! Book a meeting with CTK today and get a first look at our new technologies!  



It is Cervical Cancer Awareness Month!

January is Cervical Cancer Awareness Month. Did you know that in the United States over 10,000 women are diagnosed with invasive forms of cervical cancer each year? 3 Things you can do: Vaccinate early: Children, both male and female can receive the HPV vaccine at age 11 or 12. Pap Tests: Regular Pap tests are recommended for women over the.... Read Full Article >